Impact of haemophilia with inhibitors on caregiver burden in the United States

Mitch DeKoven, S. Karkare, W. C. Lee, L. A. Kelley, D. L. Cooper, H. Pham, J. Powers, T. Wisniewski

Research output: Contribution to journalArticle

Abstract

Inhibitor development complicates haemophilia treatment and may impact caregiver burden. Compare overall burden of caregivers of children with/without inhibitors in the United States using a novel disease-specific questionnaire and the previously validated CarerQol. An on-line questionnaire with six burden domains (i.e. emotional stress, personal sacrifice, financial burden, medical management, child's pain, and transportation) and three visual analogue scales (VAS) was developed based upon a targeted literature review and previous survey findings. The study sample consisted of caregivers of children with haemophilia. The total burden score was calculated by summing the six individual burden domain scores. Higher scores represented greater burden. Descriptive statistics was performed to examine the sample characteristics. The Wilcoxon rank-sum test was performed to compare burden by inhibitor status. All variables were considered significant at P <0.001. A total of 310 caregivers completed the survey; 30 of them reported caring for a child with an inhibitor. A majority of caregivers of children with inhibitors were mothers (80.0%) and between 35 and 44 years of age (56.7%). Caregivers of children with inhibitors reported significantly higher median total burden scores (99.0 vs. 76.5, P <0.0001) and median burden-VAS scores (5.5 vs. 3.0, P <0.0001), as compared to those caring for children without inhibitors. A similar trend was seen across all the six burden domains, with greatest difference in the median burden scores observed in the 'personal sacrifice' (3.2 vs. 2.0) and 'transportation' (3.3 vs. 2.3) domains. Burden of caregivers should be considered when assessing the psychosocial aspects of managing patients with inhibitors.

Original languageEnglish (US)
Pages (from-to)822-830
Number of pages9
JournalHaemophilia
Volume20
Issue number6
DOIs
StatePublished - Nov 1 2014
Externally publishedYes

Fingerprint

Hemophilia A
Caregivers
Nonparametric Statistics
Visual Analog Scale
Pain Management
Psychological Stress
Mothers
Surveys and Questionnaires

Keywords

  • Burden
  • Caregiver
  • Haemophilia
  • Inhibitors
  • Quality of life

ASJC Scopus subject areas

  • Hematology
  • Genetics(clinical)
  • Medicine(all)

Cite this

DeKoven, M., Karkare, S., Lee, W. C., Kelley, L. A., Cooper, D. L., Pham, H., ... Wisniewski, T. (2014). Impact of haemophilia with inhibitors on caregiver burden in the United States. Haemophilia, 20(6), 822-830. https://doi.org/10.1111/hae.12501

Impact of haemophilia with inhibitors on caregiver burden in the United States. / DeKoven, Mitch; Karkare, S.; Lee, W. C.; Kelley, L. A.; Cooper, D. L.; Pham, H.; Powers, J.; Wisniewski, T.

In: Haemophilia, Vol. 20, No. 6, 01.11.2014, p. 822-830.

Research output: Contribution to journalArticle

DeKoven, M, Karkare, S, Lee, WC, Kelley, LA, Cooper, DL, Pham, H, Powers, J & Wisniewski, T 2014, 'Impact of haemophilia with inhibitors on caregiver burden in the United States', Haemophilia, vol. 20, no. 6, pp. 822-830. https://doi.org/10.1111/hae.12501
DeKoven M, Karkare S, Lee WC, Kelley LA, Cooper DL, Pham H et al. Impact of haemophilia with inhibitors on caregiver burden in the United States. Haemophilia. 2014 Nov 1;20(6):822-830. https://doi.org/10.1111/hae.12501
DeKoven, Mitch ; Karkare, S. ; Lee, W. C. ; Kelley, L. A. ; Cooper, D. L. ; Pham, H. ; Powers, J. ; Wisniewski, T. / Impact of haemophilia with inhibitors on caregiver burden in the United States. In: Haemophilia. 2014 ; Vol. 20, No. 6. pp. 822-830.
@article{83eed155e4a0472b8ad082b6210e9154,
title = "Impact of haemophilia with inhibitors on caregiver burden in the United States",
abstract = "Inhibitor development complicates haemophilia treatment and may impact caregiver burden. Compare overall burden of caregivers of children with/without inhibitors in the United States using a novel disease-specific questionnaire and the previously validated CarerQol. An on-line questionnaire with six burden domains (i.e. emotional stress, personal sacrifice, financial burden, medical management, child's pain, and transportation) and three visual analogue scales (VAS) was developed based upon a targeted literature review and previous survey findings. The study sample consisted of caregivers of children with haemophilia. The total burden score was calculated by summing the six individual burden domain scores. Higher scores represented greater burden. Descriptive statistics was performed to examine the sample characteristics. The Wilcoxon rank-sum test was performed to compare burden by inhibitor status. All variables were considered significant at P <0.001. A total of 310 caregivers completed the survey; 30 of them reported caring for a child with an inhibitor. A majority of caregivers of children with inhibitors were mothers (80.0{\%}) and between 35 and 44 years of age (56.7{\%}). Caregivers of children with inhibitors reported significantly higher median total burden scores (99.0 vs. 76.5, P <0.0001) and median burden-VAS scores (5.5 vs. 3.0, P <0.0001), as compared to those caring for children without inhibitors. A similar trend was seen across all the six burden domains, with greatest difference in the median burden scores observed in the 'personal sacrifice' (3.2 vs. 2.0) and 'transportation' (3.3 vs. 2.3) domains. Burden of caregivers should be considered when assessing the psychosocial aspects of managing patients with inhibitors.",
keywords = "Burden, Caregiver, Haemophilia, Inhibitors, Quality of life",
author = "Mitch DeKoven and S. Karkare and Lee, {W. C.} and Kelley, {L. A.} and Cooper, {D. L.} and H. Pham and J. Powers and T. Wisniewski",
year = "2014",
month = "11",
day = "1",
doi = "10.1111/hae.12501",
language = "English (US)",
volume = "20",
pages = "822--830",
journal = "Haemophilia",
issn = "1351-8216",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Impact of haemophilia with inhibitors on caregiver burden in the United States

AU - DeKoven, Mitch

AU - Karkare, S.

AU - Lee, W. C.

AU - Kelley, L. A.

AU - Cooper, D. L.

AU - Pham, H.

AU - Powers, J.

AU - Wisniewski, T.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Inhibitor development complicates haemophilia treatment and may impact caregiver burden. Compare overall burden of caregivers of children with/without inhibitors in the United States using a novel disease-specific questionnaire and the previously validated CarerQol. An on-line questionnaire with six burden domains (i.e. emotional stress, personal sacrifice, financial burden, medical management, child's pain, and transportation) and three visual analogue scales (VAS) was developed based upon a targeted literature review and previous survey findings. The study sample consisted of caregivers of children with haemophilia. The total burden score was calculated by summing the six individual burden domain scores. Higher scores represented greater burden. Descriptive statistics was performed to examine the sample characteristics. The Wilcoxon rank-sum test was performed to compare burden by inhibitor status. All variables were considered significant at P <0.001. A total of 310 caregivers completed the survey; 30 of them reported caring for a child with an inhibitor. A majority of caregivers of children with inhibitors were mothers (80.0%) and between 35 and 44 years of age (56.7%). Caregivers of children with inhibitors reported significantly higher median total burden scores (99.0 vs. 76.5, P <0.0001) and median burden-VAS scores (5.5 vs. 3.0, P <0.0001), as compared to those caring for children without inhibitors. A similar trend was seen across all the six burden domains, with greatest difference in the median burden scores observed in the 'personal sacrifice' (3.2 vs. 2.0) and 'transportation' (3.3 vs. 2.3) domains. Burden of caregivers should be considered when assessing the psychosocial aspects of managing patients with inhibitors.

AB - Inhibitor development complicates haemophilia treatment and may impact caregiver burden. Compare overall burden of caregivers of children with/without inhibitors in the United States using a novel disease-specific questionnaire and the previously validated CarerQol. An on-line questionnaire with six burden domains (i.e. emotional stress, personal sacrifice, financial burden, medical management, child's pain, and transportation) and three visual analogue scales (VAS) was developed based upon a targeted literature review and previous survey findings. The study sample consisted of caregivers of children with haemophilia. The total burden score was calculated by summing the six individual burden domain scores. Higher scores represented greater burden. Descriptive statistics was performed to examine the sample characteristics. The Wilcoxon rank-sum test was performed to compare burden by inhibitor status. All variables were considered significant at P <0.001. A total of 310 caregivers completed the survey; 30 of them reported caring for a child with an inhibitor. A majority of caregivers of children with inhibitors were mothers (80.0%) and between 35 and 44 years of age (56.7%). Caregivers of children with inhibitors reported significantly higher median total burden scores (99.0 vs. 76.5, P <0.0001) and median burden-VAS scores (5.5 vs. 3.0, P <0.0001), as compared to those caring for children without inhibitors. A similar trend was seen across all the six burden domains, with greatest difference in the median burden scores observed in the 'personal sacrifice' (3.2 vs. 2.0) and 'transportation' (3.3 vs. 2.3) domains. Burden of caregivers should be considered when assessing the psychosocial aspects of managing patients with inhibitors.

KW - Burden

KW - Caregiver

KW - Haemophilia

KW - Inhibitors

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=84932157505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84932157505&partnerID=8YFLogxK

U2 - 10.1111/hae.12501

DO - 10.1111/hae.12501

M3 - Article

C2 - 25273645

AN - SCOPUS:84932157505

VL - 20

SP - 822

EP - 830

JO - Haemophilia

JF - Haemophilia

SN - 1351-8216

IS - 6

ER -